Prevalence and Predictors of Persistent Human Immunodeficiency Virus Viremia and Viral Rebound After Universal Test and Treat: A Population-Based Study

dc.contributor.authorGrabowski, M. Kate
dc.contributor.authorPatel, Eshan U.
dc.contributor.authorNakigozi, Gertrude
dc.contributor.authorSsempijja, Victor
dc.contributor.authorSsekubugu, Robert
dc.contributor.authorSsekasanvu, Joseph
dc.contributor.authorNdyanabo, Anthony
dc.contributor.authorKigozi, Godfrey
dc.contributor.authorNalugoda, Fred
dc.contributor.authorGray, Ronald H.
dc.contributor.authorKalibbala, Sarah
dc.contributor.authorSerwadda, David M.
dc.contributor.authorLaeyendecker, Oliver
dc.contributor.authorWawer, Maria J.
dc.contributor.authorChang, Larry W.
dc.contributor.authorQuinn, Thomas C.
dc.contributor.authorKagaayi, Joseph
dc.contributor.authorTobian, Aaron A. R.
dc.contributor.authorReynolds, Steven J.
dc.date.accessioned2022-01-20T21:49:56Z
dc.date.available2022-01-20T21:49:56Z
dc.date.issued2021
dc.description.abstractUNAIDS targets for human immunodeficiency virus (HIV) epidemic control by 2030 include that 86% of all HIV-positive persons be on antiretroviral therapy (ART) and achieve HIV viral load (VL) suppression [1]. The major policy initiative underpinning this target is universal test and treat (UTT), whereby all HIV-positive persons, irrespective of CD4 count or severity of illness, are immediately prescribed ART [2]. In sub-Saharan Africa, which accounts for more than half of all new HIV diagnoses globally, there has been considerable progress in increasing ART coverage [en_US
dc.identifier.citationGrabowski, M. K., Patel, E. U., Nakigozi, G., Ssempijja, V., Ssekubugu, R., Ssekasanvu, J., ... & Reynolds, S. J. (2021). Prevalence and Predictors of Persistent Human Immunodeficiency Virus Viremia and Viral Rebound After Universal Test and Treat: A Population-Based Study. The Journal of infectious diseases, 223(7), 1150-1160. DOI: 10.1093/infdis/jiab021en_US
dc.identifier.other10.1093/infdis/jiab021
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1367
dc.language.isoenen_US
dc.publisherThe Journal of infectious diseasesen_US
dc.subjectAfricaen_US
dc.subjectCohort studiesen_US
dc.subjectHIV preventionen_US
dc.subjectUniversal test and treaten_US
dc.subjectViral suppressionen_US
dc.titlePrevalence and Predictors of Persistent Human Immunodeficiency Virus Viremia and Viral Rebound After Universal Test and Treat: A Population-Based Studyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Prevalence and Predictors of Persistent Human.pdf
Size:
384.07 KB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: